Publications

Merideth M.A., Harney L.A., Vyas N., Bachi A., Carr A.G., Hill D.A., Dehner L.P., Schultz K.A., Stewart D.R., and Stratton P. (2020).

Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.

Anderson C., Nichols H., House M., and Sandler D.P. (2019).

Risk versus benefit of chemoprevention among raloxifene and tamoxifen users with a family history of breast cancer.

Havens P.L., Perumean-Chaney S.E., Patki A., Cofield S.S., Wilson C.M., Liu N., Anderson P.L., Landovitz R.J., Kapogiannis B.G., Hosek S.G., and Mulligan K. (2019).

Changes in bone mass after discontinuation of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine in young men who have sex with men: Extension phase results of Adolescent Trials Network Protocols 110 and 113.

Havens P.L., Tamhane A., Stephensen C.B., Schuster G.U., Gordon C.M., Liu N., Wilson C.M., Hosek S.G., Anderson P.L., Kapogiannis B.G., and Mulligan K. (2019).

Short communication: Association of vitamin D Insufficiency and protective tenofovir diphosphate concentrations with bone toxicity in adolescent boys and young men using tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis.

Mitchell R., Brown R., Fulton J., Alexander M., and Black S. (2019).

Do-it-yourself CDISC! A case study of Westat's successful implementation of CDISC standards on a fixed budget.

Lipman P.D., Dluzak L., and Stoney C.M. (2019).

Is this study feasible? Facilitating management of pragmatic trial planning milestones under a phased award funding mechanism.

Rohan E.A., Slotman B., Goettsche Tristani E., Townsend J.S., White D.E., Fultz-Butts K., and Gardner A. (2019).

Evaluating the feasibility of using a mobile app to track oncology patient navigation activities and outcomes.

Yeganeh N., Kerin T., Ank B., Watts D.H., Camarca M., Joao E.C., Pilotto J.H., Veloso V.G., Bryson Y., Gray G., Theron G., Dickover R., Morgado M.G., Santos B., Kreitchmann R., Mofenson L., and Nielsen-Saines K. (2018).

Human immunodeficiency virus antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.

Eisenach K., Demers A.-M., and Jones F. (2018).

Mycobacteriology laboratory sourcebook for harmonization and support of tuberculosis (TB) clinical trials Version 1.0.

Havens P.L., Stephensen C.B., Van Loan M.D., Schuster G.U., Woodhouse L.R., Flynn P.M., Gordon C.M., Pan C.G., Rutledge B., Harris D.R., Price G., Baker A., Meyer W.A., Wilson C.M., Hazra R., Kapogiannis B.G., Mulligan K., and Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team (2018).

Vitamin D3 supplementation increases spine bone mineral density in adolescents and young adults with human immunodeficiency virus infection being treated with tenofovir disoproxil fumarate: A randomized, placebo-controlled trial.

Havens P.L., Tamhane A., Stephensen C.B., Schuster G.U., Gordon C.M., Liu N., Wilson C.M., Hosek S.G., Anderson P.L., Kapogiannis B.G., and Mulligan K. (2018).

Association of vitamin D insufficiency and protective tenofovir diphosphate concentrations with bone toxicity in adolescent boys and young men using tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis.

Chung D.C., McCague S., Yu Z.F., Thill S., DiStefano-Pappas J., Bennett J., Cross D., Marshall K., Wellman J., and High K.A. (2018).

Novel mobility test to assess functional vision in patients with inherited retinal dystrophies.

Mollica M.A., Kent E.E., Castro K.M., Ellis E.M., Ferrer R.A., Falisi A.L., Gaysynsky A., Huang G., Palan M.A., and Chou W.S. (2018).

Perspectives on palliative care in cancer clinical trials: Diverse meanings from multidisciplinary cancer care providers.

Kapogiannis B.G., Wilson C.M., Price G.N., Harris D.R., Hazra R., Mulligan K., Havens P.L., Stephensen C.B., Flynn P.M., Rutledge B., Pan C.G., Woodhouse L.R., Van Loan M.D., Baker A., Gordon C.M., Shuster G.U., and Meyer W.A. (2018).

Vitamin D3 supplementation increases spine bone mineral density in adolescents and young adults with HIV infection being treated with tenofovir disoproxil fumarate: A randomized, placebo-controlled trial.

Mast A.E., Bialkowski W., Bryant B.J., Wright D.J., Birch R.J., Kiss J.E., D'Andrea P., Cable R.G., and Spencer B.R. (2016).

A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors.

Gohagan J.K., Prorok P.C., Yurgalevitch S., Miller A.B., Feld R., Fontana R., Jatoi I., Lawrence W., Miller A., Rajput A., Sherman M., Welch G., Wright P., and Albertsen P. (2015).

Changes in and impact of the death review process in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Substance Abuse and Mental Health Services Administration
The National Institutes of Health
AAA Foundation for Traffic Safety
The Johns Hopkins University
University of Maryland Baltimore Campus
University of Denver
U.S. Department of Veterans Affairs
U.S. Department of Transportation
U.S. Department of Justice
U.S. Department of Health and Human Services
U.S. Department of Education
U.S. Department of Agriculture
Toyota
The Verizon Foundation
Texas Education Agency
Baltimore Metropolitan Council
Teach for America
Social Security Administration
SiriusXM
Robert Wood Johnson Foundation
Organization for Economic Cooperation and Development
NYC Mayor’s Office for Economic Opportunity
National Science Foundation
Michigan Department of Health and Human Services
Maryland Cancer Registry
Internal Revenue Service
Georgia Department of Transportation
DC Public Schools
ClearWay Minnesota
Chicago Metropolitan Agency for Planning
University of Michigan
Explore Our Clients

Please wait...

Forbes 2020 The Best Employers for Diversity Powered by Statista Copyright 2019 Forbes Media LLC. Used with permissionForbes 2019: The Best Employers for Women Powered by Statista Copyright 2019 Forbes Media LLC. Used with permission

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.